title: Human monocytic ehrlichiosis in a renal transplant patient.
abstract: Human ehrlichiosis is an emerging pathogen in immunocompromised patients, potentially leading to increased morbidity compared to immunocompetent patients. A high index of suspicion is imperative and early treatment with doxycycline can be life-saving. We report the case of an immunosuppressed renal transplant patient who was diagnosed with human monocytic ehrlichiosis and successfully treated with doxycycline.
authors.affiliation: Department of Internal Medicine, Wilford Hall Medical Center, Lackland AFB, Texas 78236, USA.
authors.forename: Casey
authors.initials: C
authors.lastname: Cotant
authors.forename: Jason F
authors.initials: JF
authors.lastname: Okulicz
authors.forename: Barton
authors.initials: B
authors.lastname: Brezina
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Riley
authors.forename: Nicholas G
authors.initials: NG
authors.lastname: Conger
mesh_terms: D004318:Doxycycline / Q000627:therapeutic use; D016873:Ehrlichiosis / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged
chemical_list: D004318:Doxycycline